Urgent.News

What's breaking now, across thousands of outlets.

Business

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing

Swiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round led by Creandum, alongside a previously unannounced pre-Seed round led by First Momentum Ventures and LEA Partne...

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing

We haven't written up this one. Tech.eu has the full story — the link below goes straight to it.

Read the original at tech.eu →

More in Business

Developers urge Labour to cut red tape and boost housebuilding

The government has been urged to slash red tape and boost housebuilding in the UK as the rate of construction of new homes falls well behind Labour’s own targets. A group of property and investment leaders have handed a set of proposals to the government which they say will get stalled housing schemes moving and [...]

More from Tuesday 27 October →